83800-33-3

Usage

Uses

Used in Chemical Synthesis:
N1,N1-DIETHYL-2-FLUORO-1,4-BENZENEDIAMINE is used as an intermediate in the synthesis of various organic compounds for its ability to enhance solubility and participate in a wide range of chemical reactions.
Used in Dye Production:
In the dye industry, N1,N1-DIETHYL-2-FLUORO-1,4-BENZENEDIAMINE is used as a building block for creating dyes, contributing to the development of new colorants and pigments.
Used in Pharmaceutical Industry:
N1,N1-DIETHYL-2-FLUORO-1,4-BENZENEDIAMINE is used as a precursor in the production of pharmaceuticals, playing a crucial role in the synthesis of various medicinal compounds.
Used in Agrochemicals:
N1,N1-DIETHYL-2-FLUORO-1,4-BENZENEDIAMINE is also utilized in the agrochemical sector, serving as a key intermediate in the synthesis of pesticides and other agricultural chemicals.
Used in Materials Science:
N1,N1-DIETHYL-2-FLUORO-1,4-BENZENEDIAMINE has potential applications in materials science, where it can be used to develop new materials with specific properties.

Upstream product

• 2689-37-4 N,N-diethyl-2-fluoro-4-nitroaniline 
• 369-34-6 3,4-difluoronitrobenzene 

Downstream Products

• 1229015-19-3 2-[(3-fluoro-4-diethylamino)phenylamino]-6-(methylamino)-3-nitropyridine 
• 1229016-79-8 2-[(3-fluoro-4-diethylamino)phenylamino]-6-chloro-3-nitropyridine 

Relevant academic research and scientific papers

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The invention relates to the field of medicine, discloses new nitrogen heterocyclic derivatives, preparation method thereof and as medicament in particular as the treatment and prevention of treating tissue fibrosis of the medicament. The invention also discloses a pharmaceutically acceptable compound of the present invention comprise a pharmaceutical composition and methods for using the composition for the treatment of the human or animal tissue fibrosis of diseases, in particular for treating the human or animal renal interstitial fibrosis, glomerular sclerosis, hepatic fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, skin fibrosis, after the operation of adhering, benign prostate hypertrophy, bone-myocardial, scleroderma, multiple sclerosis, pancreas fibrosis, liver cirrhosis, myosarcoma, neurofibromatosis, interstitial pulmonary fibrosis, diabetic nephropathy, Alzheimer's disease or vascular fibrosis disease in use. (by machine translation)

Nitrogenous Heterocyclic Derivatives And Their Application In Drugs

The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis.

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis.

NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME

The present invention relates to a novel 2,6-substituted-3-nitropyridine derivative compound, a method for preparing the same, and a pharmaceutical composition including the same for prevention and treatment of osteoporosis. The 2,6-substituted-3-nitropyr

NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME

The present invention relates to a novel 2,6-substituted-3-nitropyridine derivative compound, a method for preparing the same, and a pharmaceutical composition including the same for prevention and treatment of osteoporosis. The 2,6-substituted-3-nitropyr